Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00688259 · ClinicalTrials.gov registry record · NA

Cognitive-Behavioral Therapy in Veterans With Schizophrenia

A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
122
Enrollment target
1
Study location

NCT00688259 is a NA study of Schizophrenia and Schizoaffective Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 122 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00688259, a NA study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
1
Study location

Study Summary

This is a study comparing the benefits of two types of individual psychotherapy (cognitive-behavioral therapy for psychosis and supportive therapy) in symptomatic Veteran outpatients diagnosed with schizophrenia or schizoaffective disorder. Treatment lasted approximately 6 months, with outcome data on symptoms, functioning, and distress levels collected at baseline, post-treatment, and 6 months post -treatment follow-up.

Interventions

  • BEHAVIORAL Supportive Therapy (ST)
  • BEHAVIORAL Cognitive Behavioral Therapy for Psychosis (CBTp)

Study Locations (1)

California

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2009-04
Est. Completion 2015-01
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00688259

The ClinicalTrials.gov registry entry for NCT00688259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Supportive Therapy (ST) is the first listed.

NCT00688259 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00688259 about?

NCT00688259 is a clinical study titled "Cognitive-Behavioral Therapy in Veterans With Schizophrenia". This is a study comparing the benefits of two types of individual psychotherapy (cognitive-behavioral therapy for psychosis and supportive therapy) in symptomatic Veteran outpatients diagnosed with schizophrenia or schizoaffective disorder. Treatment lasted approximately 6 months, with outcome data ...

What is the current status of trial NCT00688259?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2009-04. Estimated completion is 2015-01.

What conditions does trial NCT00688259 study?

This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.

What interventions are being tested in trial NCT00688259?

The interventions under investigation include: Supportive Therapy (ST) (BEHAVIORAL), Cognitive Behavioral Therapy for Psychosis (CBTp) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00688259?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00688259 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.